Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$2.6 - $5.16 $36 - $72
-14 Reduced 4.93%
270 $2,000
Q2 2022

Jul 18, 2022

BUY
$2.46 - $5.2 $698 - $1,476
284 New
284 $1,000
Q1 2022

Apr 19, 2022

SELL
$4.16 - $9.08 $116 - $254
-28 Closed
0 $0
Q4 2021

Jan 24, 2022

BUY
$7.65 - $11.38 $68 - $102
9 Added 47.37%
28 $0
Q2 2021

Jul 13, 2021

BUY
$11.87 - $15.96 $225 - $303
19 New
19 $0

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.